Title:
癌の標的付けられた治療のためのタキサン誘導体
Document Type and Number:
Japanese Patent JP4808846
Kind Code:
B2
Abstract:
The present invention describes for the first time the design and synthesis of a soluble tumor-directed paclitaxel prodrug which may establish a new mode of utilization of the taxane class of anticancer agents in cancer therapy.
Inventors:
Safavie, ahmad
Application Number:
JP2000600669A
Publication Date:
November 02, 2011
Filing Date:
February 23, 2000
Export Citation:
Assignee:
The U-B Research Research Foundation
International Classes:
A61K47/48; A61K31/337; A61P35/00
Domestic Patent References:
| JPH0770175A | 1995-03-14 | |||
| JP2005533026A | 2005-11-04 | |||
| JP2003514903A | 2003-04-22 | |||
| JP2011042679A | 2011-03-03 |
Foreign References:
| WO1998013059A1 | 1998-04-02 | |||
| WO2001074399A1 | 2001-10-11 | |||
| WO1998019705A1 | 1998-05-14 | |||
| WO1996040210A1 | 1996-12-19 | |||
| WO1999025729A1 | 1999-05-27 |
Attorney, Agent or Firm:
Yanagita Seiji
Go Sakuma
Go Sakuma